CN114917303A - 一种治疗鼻炎的中药组合物及其制备方法与应用 - Google Patents
一种治疗鼻炎的中药组合物及其制备方法与应用 Download PDFInfo
- Publication number
- CN114917303A CN114917303A CN202210599100.5A CN202210599100A CN114917303A CN 114917303 A CN114917303 A CN 114917303A CN 202210599100 A CN202210599100 A CN 202210599100A CN 114917303 A CN114917303 A CN 114917303A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- root
- chinese medicine
- seed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 72
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 206010039083 rhinitis Diseases 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241000218378 Magnolia Species 0.000 claims abstract description 21
- 229940079593 drug Drugs 0.000 claims abstract description 19
- 241000195955 Equisetum hyemale Species 0.000 claims abstract description 18
- 244000036905 Benincasa cerifera Species 0.000 claims abstract description 17
- 235000011274 Benincasa cerifera Nutrition 0.000 claims abstract description 17
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 17
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 17
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 17
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 17
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 17
- 240000000249 Morus alba Species 0.000 claims abstract description 17
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 241000931705 Cicada Species 0.000 claims abstract description 16
- 241000758794 Asarum Species 0.000 claims abstract description 15
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 15
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 15
- 244000112814 pipewort Species 0.000 claims abstract description 15
- 240000007078 Peucedanum palustre Species 0.000 claims abstract description 14
- 235000008040 Peucedanum palustre Nutrition 0.000 claims abstract description 14
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 14
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 14
- 235000011477 liquorice Nutrition 0.000 claims abstract description 14
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 6
- 241000050051 Chelone glabra Species 0.000 claims abstract 5
- 235000006751 Platycodon Nutrition 0.000 claims description 11
- 229930189914 platycodon Natural products 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 241000723353 Chrysanthemum Species 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 206010028748 Nasal obstruction Diseases 0.000 abstract description 15
- 208000024891 symptom Diseases 0.000 abstract description 15
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract description 12
- 206010039101 Rhinorrhoea Diseases 0.000 abstract description 12
- 230000001105 regulatory effect Effects 0.000 abstract description 9
- 208000010753 nasal discharge Diseases 0.000 abstract description 6
- 208000006673 asthma Diseases 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 5
- 210000001835 viscera Anatomy 0.000 abstract description 4
- 206010060891 General symptom Diseases 0.000 abstract description 3
- 208000000592 Nasal Polyps Diseases 0.000 abstract description 3
- 230000001684 chronic effect Effects 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 3
- 230000006058 immune tolerance Effects 0.000 abstract description 3
- 208000016366 nasal cavity polyp Diseases 0.000 abstract description 3
- 230000028327 secretion Effects 0.000 abstract description 3
- 206010041232 sneezing Diseases 0.000 abstract description 3
- 238000013329 compounding Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 25
- 230000000144 pharmacologic effect Effects 0.000 description 20
- 210000004072 lung Anatomy 0.000 description 16
- 238000011160 research Methods 0.000 description 15
- 206010061218 Inflammation Diseases 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 241000207929 Scutellaria Species 0.000 description 11
- 230000004054 inflammatory process Effects 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 208000036071 Rhinorrhea Diseases 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 235000008216 herbs Nutrition 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 240000003582 Platycodon grandiflorus Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 229960002744 mometasone furoate Drugs 0.000 description 3
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 description 3
- 239000007922 nasal spray Substances 0.000 description 3
- 229940097496 nasal spray Drugs 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 210000001331 nose Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 235000013719 Houttuynia cordata Nutrition 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 241000244269 Peucedanum Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010002653 Anosmia Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010050515 Hyposmia Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 235000019559 hyposmia Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- DIVDFFZHCJEHGG-UHFFFAOYSA-N oxidopamine Chemical compound NCCC1=CC(O)=C(O)C=C1O DIVDFFZHCJEHGG-UHFFFAOYSA-N 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Neurosurgery (AREA)
- Otolaryngology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗鼻炎的中药组合物及其制备方法与应用,属于中药复配技术领域。该中药组合物包括以下重量份的原料药:谷精草4~20份、木贼2~12份、决明子2~12份、桑叶2~14份、菊花2~14份、前胡1~4份、辛夷2~8份、冬瓜子6~12份、蝉蜕2~6份、薏苡仁6~12份、黄芩2~8份、鱼腥草3~7份、甘草2~3份、乌梅2~3份、桔梗1~2份。本发明的中药组合物可通过调节脏腑功能提高机体对外环境的免疫耐受能力,减少鼻腔分泌物,迅速缓解患者打喷嚏、流清涕、鼻塞等症状,改善并缓解鼻息肉、鼻窦炎的发生发展及全身症状,降低复发率,减少出现变异性哮喘及慢性支气管症状。
Description
技术领域
本发明属于中药复配技术领域,涉及一种治疗鼻炎的中药组合物及其制备方法与应用。
背景技术
鼻炎即鼻腔炎性疾病,是病毒、细菌、变应原、各种理化因子以及某些全身性疾病引起的鼻腔黏膜的炎症。鼻炎的主要病理改变是鼻腔黏膜充血、肿胀、渗出、增生、萎缩或坏死等。鼻炎的主要症状有鼻塞、多涕、嗅觉下降、咳嗽、头疼、头晕、以及记忆力减退等等。现有西医技术方面多采取抗生素、激素、血管收缩剂等手段治疗。西医的方法起效快但难以持续,且部分药物长时间使用后易出现不良反应及耐药性。
发明内容
本发明的目的在于克服现有技术的不足,提供一种治疗鼻炎的中药组合物及其制备方法与应用。
为实现上述目的,本发明采取的技术方案为:第一方面,提供一种治疗鼻炎的中药组合物,包括以下重量份的原料药:谷精草4~20份、木贼2~12份、决明子2~12份、桑叶2~14份、菊花2~14份、前胡1~4份、辛夷2~8份、冬瓜子6~12份、蝉蜕2~6份、薏苡仁6~12份、黄芩2~8份、鱼腥草3~7份、甘草2~3份、乌梅2~3份、桔梗1~2份。
鼻炎在中医又称作鼻渊,鼻窒,中医认为是指由于脏腑虚损、卫表不固所致的,基于中医“正气”理论,治疗的核心是让患者“正气存内”。要注重补正气,扶正祛邪,尽快消灭炎症因子,通鼻窍,恢复机体正常功能。同时中药能着眼于“过敏”的人体内环境,即改善患者特应性体质对变应性的治疗意义重大。中医药治疗该病疗效显著,虽治疗周期较长,但复发率较低,且干预手段较多,优势独特。本发明的中药组合物可通过调节脏腑功能提高机体对外环境的免疫耐受能力,减少鼻腔分泌物,迅速缓解患者打喷嚏、流清涕、鼻塞等症状,改善并缓解鼻息肉、鼻窦炎的发生发展及全身症状,降低复发率,减少出现变异性哮喘及慢性支气管症状。
方中,各原料要的药理疗效如下:
谷精草:辛、甘、凉,归肝、胃经。疏散风热、治鼻衄,喉痹,目翳,雀盲,头痛,齿痛。现代药理研究表明谷精草具有抗菌、抗氧化、α-葡萄糖苷酶抑制、6-OHDA诱导神经损伤保护等作用。
木贼:甘、苦、平,归肺、肝经。疏散风热、治吐风狂痰涎。现代药理研究显示木贼有抗菌、抗病毒之功用,所含硅酸盐和鞣质有收敛作用。
辛夷:辛、温,归肺、胃经。发散风寒、宣通鼻窍。现代药理研究发现其中有效成分挥发油具有抗炎、抗过敏、抗菌作用。
决明子:甘苦咸、微寒,归肝肾、大肠经。清肝明目、润肠通便。现代药理研究表明决明子所含活性成分具有降血脂、降血压、抑菌等作用。
桑叶:甘、苦、寒,归肺、肝经。发散风热、润肺止咳、平肝明目。现代药理研究发现,桑叶成分中均含有黄酮类、生物碱类等多种活性成分,具有抗炎、抑菌、抗氧化、抗凝血及扩血管等多种药理作用。
菊花:辛甘苦、微寒,归肺、肝经。发散风热、清肝明目、平抑肝阳、清热解毒。现代药理研究显示菊花含有黄酮类、挥发油类等化学成分,具有抗炎、抗氧化、抗衰老等药理作用。
前胡:苦、辛、微寒,归肺经。降气化痰、宣散风热。现代药理研究表明前胡有镇咳、平喘、抗炎、解痉、镇静等。
冬瓜子:甘、微寒,归肺、小肠经。利水消肿。现代药理研究发现冬瓜子还能发挥抗炎解热镇痛,抑菌抗肿瘤,抗氧化除痰,抗糖尿病等药理作用。
蝉蜕:甘、咸,凉,归肺、肝经。疏散风热,利咽开音,透疹,明目退翳,息风止痉。现代药理研究提示蝉蜕亦有抗炎、镇咳祛痰平喘等作用。
薏苡仁:甘、淡、微寒,归脾、胃肺经。利水渗湿、健脾止泻、清热排脓、除痹。现代药理研究认为薏苡仁具有抗肿瘤,提高机体免疫力,降低血糖,抗炎镇痛的功效。
黄芩:苦、寒,归肺胃胆大肠经。清热燥湿、泻火解毒、止血、安胎。现代药理研究表明黄芩具有解热、抗炎、免疫调节作用。
鱼腥草:寒、苦、辛,入肝、肺二经。清热解毒,利尿消肿。现代药理研究表明鱼腥草具有抗炎、抗肿瘤、抗病毒、抑菌、免疫调节和增强机体免疫等作用。
甘草:甘、平,归、心、肺、脾、胃经。益气补中、清热解毒、祛痰止咳、缓急止痛、调和药性。现代药理研究发现甘草具有抗炎、抗癌、抗病毒、保肝等多种功效。
乌梅:酸、涩、平,归肝脾肺大肠经。敛肺止咳、涩肠止泻、生津止渴、安蛔止痛。现代药理研究表明乌梅可调节免疫、抗肿瘤、降血糖、抗炎、解热止痛、抗溃疡等作用。
桔梗:苦、辛、平,归肺经。开宣肺气、祛痰排脓、利咽。现代药理研究表明桔梗还有解热镇痛、抗炎、抗溃疡、免疫调节、保肝、抗肿瘤、抗高血糖、调血脂等多种药理作用。
方中诸药配伍,具有很好的升清阳、通鼻窍、祛脓涕之功,正气自足使患者增质固表抗敏。全方既解头痛、鼻塞、流涕等表征,又能调节等致病根本,且全方寒热并用,配伍合理,甘草性味归甘,既避免偏性过大,又可缓和药物的苦味。
优选地,所述中药组合物包括以下重量份的原料药:谷精草4~7份、木贼2~5份、决明子2~5份、桑叶2~4份、菊花2~5份、前胡1~3份、辛夷2~6份、冬瓜子6~8份、蝉蜕2~4份、薏苡仁6~8份、黄芩2~6份、鱼腥草3~5份、甘草2~3份、乌梅2~3份、桔梗1~2份。
本发明的发明人对该中药组合物进行了药效试验,发现在上述配比范围内,该组合物在治疗鼻炎方面具有更好的效果。
优选地,所述中药组合物包括以下重量份的原料药:谷精草4份、木贼2份、决明子2份、桑叶2份、菊花2份、前胡1份、辛夷2份、冬瓜子6份、蝉蜕2份、薏苡仁6份、黄芩2份、鱼腥草3份、甘草2份、乌梅2份、桔梗1份。
发明人发现,中药组合物的原料药在上述配比下,该组合物在治疗鼻炎方面的效果最佳。
优选地,所述中药组合物包括以下重量份的原料药:7份、木贼5份、决明子5份、桑叶4份、菊花5份、前胡3份、辛夷6份、冬瓜子8份、蝉蜕4份、薏苡仁8份、黄芩6份、鱼腥草5份、甘草3份、乌梅2份、桔梗1份。
第二方面,提供一种中药组合物的制备方法,包括以下步骤:将谷精草、木贼、决明子、桑叶、菊花、前胡、辛夷、冬瓜子、蝉蜕、薏苡仁、黄芩、鱼腥草、甘草、乌梅、桔梗混合后,加水煎煮提取,煎煮结束后过滤固体药渣,所得滤液即为中药组合物。
第三方面,提供一种中药制剂,其包含本发明第一方面所述中药组合物。
第四方面,提供一种治疗鼻炎的药物,其包含本发明第一方面所述中药组合物。
第五方面,提供本发明第一方面所述中药组合物在制备治疗鼻炎的药物中的应用。
与现有技术相比,本发明的有益效果为:本发明的中药组合物可通过调节脏腑功能提高机体对外环境的免疫耐受能力,减少鼻腔分泌物,迅速缓解患者打喷嚏和流清涕鼻塞等症状,改善并缓解鼻息肉、鼻窦炎的发生发展及全身症状,降低复发率,减少出现变异性哮喘及慢性支气管症状。
具体实施方式
为更好的说明本发明的目的、技术方案和优点,下面将结合具体实施例对本发明作进一步的说明。
实施例1
本实施例提供了一种治疗鼻炎的中药组合物,由以下重量份的原料药组成:谷精草4份、木贼2份、决明子2份、桑叶2份、菊花2份、前胡1份、辛夷2份、冬瓜子6份、蝉蜕2份、薏苡仁6份、黄芩2份、鱼腥草3份、甘草2份、乌梅2份、桔梗1份。
本实施例还提供了一种治疗鼻炎的中药组合物的制备方法,包括以下步骤:
称取谷精草4份、木贼2份、决明子2份、桑叶2份、菊花2份、前胡1份、辛夷2份、冬瓜子6份、蝉蜕2份、薏苡仁6份、黄芩2份、鱼腥草3份、甘草2份、乌梅2份、桔梗1份,用纱布包裹辛夷,与其他原料药混合均匀后,加入中药总质量8倍的水中,加热煎煮,沸腾后计时,煎煮半小时,结束后过滤,所得滤液即为治疗鼻炎的中药煎剂。
实施例2
本实施例提供了一种治疗鼻炎的中药组合物,由以下重量份的原料药组成:谷精草7份、木贼5份、决明子5份、桑叶4份、菊花5份、前胡3份、辛夷6份、冬瓜子8份、蝉蜕4份、薏苡仁8份、黄芩6份、鱼腥草5份、甘草3份、乌梅2份、桔梗1份。
本实施例还提供了一种治疗鼻炎的中药组合物的制备方法,包括以下步骤:
称取谷精草7份、木贼5份、决明子5份、桑叶4份、菊花5份、前胡3份、辛夷6份、冬瓜子8份、蝉蜕4份、薏苡仁8份、黄芩6份、鱼腥草5份、甘草3份、乌梅2份、桔梗1份,用纱布包裹辛夷,与其他原料药混合均匀后,加入中药总质量10倍的水中,加热煎煮,沸腾后计时,煎煮半小时,结束后过滤,所得滤液即为治疗鼻炎的中药煎剂。
实施例3
本实施例提供了一种治疗鼻炎的中药组合物,由以下重量份的原料药组成:谷精草20份、木贼12份、决明子12份、桑叶14份、菊花14份、前胡4份、辛夷8份、冬瓜子12份、蝉蜕6份、薏苡仁12份、黄芩8份、鱼腥草7份、甘草3份、乌梅3份、桔梗2份。
本实施例还提供了一种治疗鼻炎的中药组合物的制备方法,包括以下步骤:
称取谷精草20份、木贼12份、决明子12份、桑叶14份、菊花14份、前胡4份、辛夷8份、冬瓜子12份、蝉蜕6份、薏苡仁12份、黄芩8份、鱼腥草7份、甘草3份、乌梅3份、桔梗2份,用纱布包裹辛夷,与其他原料药混合均匀后,加入中药总质量12倍的水中,加热煎煮,沸腾后计时,煎煮半小时,结束后过滤,所得滤液即为治疗鼻炎的中药煎剂。
效果例1
本效果例提供了一种治疗鼻炎的中药组合物的应用效果试验。
(一)患者情况:观察病例168例,均为鼻炎患者,年龄在3-80岁,病程≥4周,将患者随机分为两组,每组84人。
(二)治疗方法
观察组患者均采用实施例1的中药煎剂口服,联合糠酸莫米松鼻喷雾剂进行治疗;对照组患者均采用糠酸莫米松鼻喷雾剂进行治疗;中药煎剂的使用方法为:水煎至200ml,早晚餐后各温服一次;糠酸莫米松鼻喷雾剂的使用方法为:每侧鼻孔2喷,每喷为50μg,总量为200μg,一日1次。各组用药共3周,观察各组治疗前后的积分变化。
(三)治疗标准:
根据《中药新药临床研究指导原则》,以鼻塞、流鼻涕、鼻痒、喷嚏的TNSS评分来判断综合疗效,将疗效标准分为痊愈、显效、有效、无效4个等级。
疗效指数=(治疗前TNSS分值-治疗后TNSS分值)/治疗前TNSS分值×100%;
(1)治愈:鼻塞、流鼻涕、鼻痒、喷嚏症状全部消失,治疗指数≥95%;
(2)显效:鼻塞、流鼻涕、鼻痒、喷嚏症状明显减轻,70%≤疗效指数<95%;
(3)好转:鼻塞、流鼻涕、鼻痒、喷嚏症状有所改善,50%≤疗效指数<70%;
(4)无效:鼻塞、流鼻涕、鼻痒、喷嚏症状未见减轻,疗效指数<50%。
总有效率=(痊愈例数+显效例数+有效例数)/治疗总例数×100%。
应用数据处理与统计学分析:Excel整理数据库,应用SPSS20.0统计软件进行统计分析,所有数据均以X±S表示。组间比较采用t检验,计数资料的比较采用χ2检验,P<0.05为差异有统计学意义。
(四)治疗效果
治疗前,对各组症候总积分进行比较,得出P>0.05,差异无统计学意义,表明各组症候总积分具有可比性。各组治疗后中医症候总积分比较结果如表1所示:
上述结果表明,与对照组相比,观察组更有效缓解鼻炎症状。
表2各组治疗后总有效率比较[例(%)]
从表2的结果可以看出,本发明的中药组合物对鼻炎的治疗作用显著,经观察发现,本发明的中药组合物无明显不良反应。
典型病例
谢某,男,6岁,鼻塞流涕1年,加重1周,用药4周痊愈;一年后回访,未复发。
蔡某,女,16岁,鼻塞2年,咳嗽、流涕并伴头痛记忆力减退,咽部异物感,用药7周后痊愈;一年后回访,未复发。
王某,女,35岁,间断鼻塞10年伴记忆力减退并伴有耳鸣、流泪等,用药8周痊愈;随访一年未复发。
郑某,男,52岁,鼻塞、流涕、头疼4个月,用药3周痊愈;随访一年未复发。
最后所应当说明的是,以上实施例用以说明本发明的技术方案而非对本发明保护范围的限制,尽管参照较佳实施例对本发明作了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者同等替换,而不脱离本发明技术方案的实质和范围。
Claims (8)
1.一种治疗鼻炎的中药组合物,其特征在于,包括以下重量份的原料药:谷精草4~20份、木贼2~12份、决明子2~12份、桑叶2~14份、菊花2~14份、前胡1~4份、辛夷2~8份、冬瓜子6~12份、蝉蜕2~6份、薏苡仁6~12份、黄芩2~8份、鱼腥草3~7份、甘草2~3份、乌梅2~3份、桔梗1~2份。
2.如权利要求1所述的中药组合物,其特征在于,包括以下重量份的原料药:谷精草4~7份、木贼2~5份、决明子2~5份、桑叶2~4份、菊花2~5份、前胡1~3份、辛夷2~6份、冬瓜子6~8份、蝉蜕2~4份、薏苡仁6~8份、黄芩2~6份、鱼腥草3~5份、甘草2~3份、乌梅2~3份、桔梗1~2份。
3.如权利要求2所述的中药组合物,其特征在于,包括以下重量份的原料药:谷精草4份、木贼2份、决明子2份、桑叶2份、菊花2份、前胡1份、辛夷2份、冬瓜子6份、蝉蜕2份、薏苡仁6份、黄芩2份、鱼腥草3份、甘草2份、乌梅2份、桔梗1份。
4.如权利要求2所述的中药组合物,其特征在于,包括以下重量份的原料药:7份、木贼5份、决明子5份、桑叶4份、菊花5份、前胡3份、辛夷6份、冬瓜子8份、蝉蜕4份、薏苡仁8份、黄芩6份、鱼腥草5份、甘草3份、乌梅2份、桔梗1份。
5.一种如权利要求1~4任一项所述中药组合物的制备方法,其特征在于,包括以下步骤:将谷精草、木贼、决明子、桑叶、菊花、前胡、辛夷、冬瓜子、蝉蜕、薏苡仁、黄芩、鱼腥草、甘草、乌梅、桔梗混合后,加水煎煮提取,煎煮结束后过滤固体药渣,所得滤液即为中药组合物。
6.一种中药制剂,其特征在于,其包含权利要求1~4任一项所述中药组合物。
7.一种治疗鼻炎的药物,其特征在于,包含权利要求1~4任一项所述中药组合物。
8.一种如权利要求1~4任一项所述中药组合物在制备治疗鼻炎的药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210599100.5A CN114917303A (zh) | 2022-05-30 | 2022-05-30 | 一种治疗鼻炎的中药组合物及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210599100.5A CN114917303A (zh) | 2022-05-30 | 2022-05-30 | 一种治疗鼻炎的中药组合物及其制备方法与应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114917303A true CN114917303A (zh) | 2022-08-19 |
Family
ID=82813030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210599100.5A Pending CN114917303A (zh) | 2022-05-30 | 2022-05-30 | 一种治疗鼻炎的中药组合物及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114917303A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104547046A (zh) * | 2014-12-17 | 2015-04-29 | 蓝春秀 | 一种应用于治疗鼻窦炎的中药组分 |
CN106581256A (zh) * | 2016-12-30 | 2017-04-26 | 河南科技大学 | 一种用于治疗鼻窦炎的中药组合物、药物制剂及其制备方法 |
CN107714820A (zh) * | 2017-09-26 | 2018-02-23 | 成都中医药大学附属医院 | 一种治疗过敏性鼻炎的药物组合物及其制备方法和用途 |
-
2022
- 2022-05-30 CN CN202210599100.5A patent/CN114917303A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104547046A (zh) * | 2014-12-17 | 2015-04-29 | 蓝春秀 | 一种应用于治疗鼻窦炎的中药组分 |
CN106581256A (zh) * | 2016-12-30 | 2017-04-26 | 河南科技大学 | 一种用于治疗鼻窦炎的中药组合物、药物制剂及其制备方法 |
CN107714820A (zh) * | 2017-09-26 | 2018-02-23 | 成都中医药大学附属医院 | 一种治疗过敏性鼻炎的药物组合物及其制备方法和用途 |
Non-Patent Citations (2)
Title |
---|
王子英: "畅窦汤治疗鼻渊实热证96例疗效观察" * |
陶洁: "谷青汤治疗风(郁)热证鼻渊50例观察" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102198236B (zh) | 一种治疗急性鼻窦炎的中药组合物及其制备方法 | |
CN105497486A (zh) | 一种治疗慢性鼻炎的中药组合物 | |
CN102526459B (zh) | 一种治疗鼻窦炎的中药组合物及其制备方法 | |
CN104623379B (zh) | 一种治疗小儿手足口病的药物组合物 | |
CN114917303A (zh) | 一种治疗鼻炎的中药组合物及其制备方法与应用 | |
CN103479920B (zh) | 一种治疗哮喘的药物 | |
CN105233252A (zh) | 一种治疗急性化脓性胆管炎的中西药复方制剂 | |
WO2021103777A1 (zh) | 一种用于儿童、青少年过敏性哮喘合并过敏性鼻炎防治的喷雾剂 | |
CN105833034A (zh) | 一种治疗哮喘的中药组合物 | |
CN105327182A (zh) | 一种治疗儿童百日咳的药物及其制备方法 | |
CN104623217A (zh) | 一种治疗哮喘的中药制剂及制备方法 | |
CN115252732B (zh) | 一种清肺止咳的中药组合物及其应用 | |
CN112057561B (zh) | 一种治疗过敏性鼻炎的中药鼻喷雾剂 | |
CN109106842B (zh) | 一种用于戒烟的药物及其制备方法 | |
CN105833063A (zh) | 一种治疗慢性支气管炎的中药组合物 | |
CN105497638A (zh) | 一种治疗放射性鼻窦炎的中药制剂及其制备方法 | |
CN105833094A (zh) | 一种治疗沙眼的中药组合物 | |
CN104771629A (zh) | 一种用于治疗咽炎的中药制剂 | |
CN113599450A (zh) | 一种治疗小儿肺炎喘嗽的中药口服液及其制备方法 | |
CN103977296A (zh) | 一种治疗尿道炎的中药口服液及制备方法 | |
CN1284554C (zh) | 一种治疗急性型寻麻疹疾病的药 | |
CN118634291A (zh) | 一种治疗多种咳嗽和急慢性支气管哮喘的药物及其制备方法 | |
CN104189610A (zh) | 一种治疗支气管炎的中药组合物 | |
CN113925895A (zh) | 一种治疗急慢性鼻炎的中药组合物、口服制剂及其制备方法 | |
CN113262289A (zh) | 治疗鼻及鼻窦炎的中药组合物、制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220819 |